In addition, an elevated expression of MMP-9 and downregulation of E-cadherin have been found to associate with poorly differentiated gastric carcinoma and lymph-node metastasis, and together with increased levels of VEGF and MMP-2, they can serve as malignancy markers in gastric cancer [78,126,128]. This evidence concerns the gene MMP9 and gastric cancer.